Details for Patent: 6,071,970
✉ Email this page to a colleague
Summary for Patent: 6,071,970
| Title: | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| Abstract: | Method and compositions for treating a patient having a neurological disease or disorder, such as stroke, head trauma, spinal cord injury, epilepsy, anxiety, or neurodegenerative diseases such as Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, or amyotrophic lateral sclerosis (ALS). |
| Inventor(s): | Alan L. Mueller, Manuel F. Balandrin, Bradford C. VanWagenen, Eric G. DelMar, Scott T. Moe, Linda D. Artman, Robert M. Barmore |
| Assignee: | Shire NPS Pharmaceuticals Inc |
| Application Number: | US08/485,038 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 6,071,970
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,071,970
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 200862 | ⤷ Start Trial | |||
| Austria | 238782 | ⤷ Start Trial | |||
| Austria | 346595 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
